Published in Exp Hematol on August 01, 1983
The molecular basis for Na-dependent phosphate transport in human erythrocytes and K562 cells. J Gen Physiol (2000) 0.88
Pyruvate kinase and the "high ATP syndrome". J Clin Invest (1984) 0.77
Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (1992) 9.32
Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature (1992) 4.45
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature (1992) 4.44
Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat Cell Biol (2000) 3.49
Functional analysis of 150 deletion mutants in Saccharomyces cerevisiae by a systematic approach. Mol Gen Genet (1999) 2.26
Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med (1977) 2.12
Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res (1992) 2.00
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol (1996) 1.75
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res (1999) 1.72
Functional studies on lymphocytes in adult human bone marrow. II. Isolated surface IgM-positive cells. J Immunol (1979) 1.70
Identification of connexin43 as a functional target for Wnt signalling. J Cell Sci (1998) 1.64
Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J Clin Invest (1978) 1.61
Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization. Am J Dis Child (1993) 1.61
Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology (2000) 1.60
MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A (1999) 1.59
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx. Proc Natl Acad Sci U S A (1994) 1.55
Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine (1997) 1.44
Structure and genomic sequence of the myotonic dystrophy (DM kinase) gene. Hum Mol Genet (1993) 1.44
p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem (2000) 1.44
Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood (1994) 1.39
p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases. Oncogene (1998) 1.38
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin Cancer Res (1999) 1.38
Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts. FEBS Lett (1998) 1.36
Purification and properties of glutathione reductase of human erythrocytes. Biochim Biophys Acta (1969) 1.31
Endocytosis of GPI-linked membrane folate receptor-alpha. J Cell Biol (1996) 1.31
Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivatives, preceded by a simple and rapid prepurification method. Clin Chim Acta (1986) 1.31
Density-functional theory-symmetry-adapted intermolecular perturbation theory with density fitting: a new efficient method to study intermolecular interaction energies. J Chem Phys (2005) 1.30
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells. Leukemia (2011) 1.29
Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet (1993) 1.28
Human erythrocyte pyruvate kinase. Its purification and some properties. Biochim Biophys Acta (1971) 1.25
Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer. J Clin Oncol (2002) 1.22
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood (1999) 1.20
Characterization of alpha-L-fucosidase from two different families with fucosidosis. Clin Chim Acta (1976) 1.20
Brief report: reverse mutation in myotonic dystrophy. N Engl J Med (1993) 1.19
Relationship between allergic manifestations and Toxocara seropositivity: a cross-sectional study among elementary school children. Eur Respir J (1997) 1.17
Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol (1998) 1.17
Specific lymphocyte stimulation by purified, heat-inactivated hepatitis-B antigen. Br Med J (1973) 1.16
Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res (2001) 1.14
Lymphocyte 5'-nucleotidase in primary hypogammaglobulinaemia and cord blood. Clin Exp Immunol (1980) 1.14
Ste50p is involved in regulating filamentous growth in the yeast Saccharomyces cerevisiae and associates with Ste11p. Mol Gen Genet (1998) 1.14
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection. J Clin Microbiol (1990) 1.14
Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha. Ann Rheum Dis (2004) 1.13
The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand (1973) 1.11
Ste50p sustains mating pheromone-induced signal transduction in the yeast Saccharomyces cerevisiae. Mol Microbiol (1996) 1.11
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. Clin Exp Immunol (1978) 1.10
Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells? Crit Rev Oncol Hematol (2012) 1.08
Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. Hum Mol Genet (2000) 1.08
Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE. Immunology (1990) 1.08
Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol (1997) 1.07
Is cytomegalovirus infection a major cause of T cell alterations after (autologous) bone-marrow transplantation? Lancet (1984) 1.07
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia (2000) 1.05
Is booster injection with hepatitis B vaccine necessary in healthy responders? A study of the immune response. J Hepatol (1989) 1.04
Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Pediatrics (1989) 1.03
Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood (1997) 1.03
An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity. Clin Chim Acta (1976) 1.03
Presymptomatic diagnosis of myotonic dystrophy. J Med Genet (1992) 1.02
Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med (1998) 1.01
Detection of cytomegalovirus (CMV) in granulocytes by polymerase chain reaction compared with the CMV antigen test. J Clin Microbiol (1992) 1.01
Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue. Cancer Res (1989) 1.01
Associated expression of CD1 antigen and Fc receptor for IgE on epidermal Langerhans cells from patients with atopic dermatitis. Clin Exp Immunol (1988) 1.00
Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer (1991) 1.00
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase. Clin Cancer Res (1997) 1.00
Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates. J Biol Chem (1990) 0.99
Purification and some properties of human erythrocyte hexokinase. Biochim Biophys Acta (1976) 0.99
Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Thorax (1977) 0.99
CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes. Eur J Immunol (1999) 0.99
Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol (1998) 0.99
The role of initial immunotherapy as selection for nephrectomy in patients with metastatic renal cell carcinoma and the primary tumor in situ. Eur Urol (2002) 0.99
Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs. Ann Rheum Dis (2004) 0.97
The reaction mechanism of glutathione reductase from human erythrocytes. Biochim Biophys Acta (1969) 0.97
Effect of twelve antimicrobial drugs on the colonization resistance of the digestive tract of mice and on endogenous potentially pathogenic bacteria. J Hyg (Lond) (1982) 0.97
Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates. Int J Cancer (2000) 0.96
Short communication: imputing genotypes using PedImpute fast algorithm combining pedigree and population information. J Dairy Sci (2013) 0.96
Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J (1985) 0.96
Glycolytic enzyme activities in breast cancer metastases. Tumour Biol (1988) 0.96
Functional studies on lymphocytes in adult human bone marrow. I. Immunoglobulin production in vitro after fractionation on a sucrose gradient and T/non-T cell separation. J Immunol (1979) 0.95
Enhanced expression of fractalkine in HIV-1 associated dementia. J Neuroimmunol (2001) 0.95
Synthesis and biological evaluation of a fluorescent analogue of folic acid. Biochemistry (1991) 0.95
Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors. Br J Cancer (2008) 0.95
Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease. Br J Haematol (1999) 0.94
The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients. Clin Exp Rheumatol (2009) 0.94
Herpes-virus immunity and acute graft-versus-host disease. Lancet (1987) 0.93
Delay in platelet recovery after bone marrow transplantation: impact of cytomegalovirus infection. Blood (1985) 0.93
Expression of a folate binding protein in L1210 cells grown in low folate medium. Cancer Res (1989) 0.93
Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest (1980) 0.93
Regulation of human erythrocyte hexokinase. The influence of glycolytic intermediates and inorganic phosphate. Biochim Biophys Acta (1977) 0.92
Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems. Cancer Res (1991) 0.92
Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum Mol Genet (1993) 0.91
Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial). Thorax (1978) 0.91
Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch-Nyhan syndrome. Hum Genet (1981) 0.91
Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol (1987) 0.91